FdaApplication
ANDA 220225
Identifiers
- fda_app_no: ANDA220225
Properties
| Property | Value |
|---|---|
| applicant_name | ALEMBIC PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2026-04-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
2 products